Advanced Biomanufacturing

Researchers from The University of Queensland are using synthetic biology to help the world’s biggest businesses transition to net zero.

A new facility at the Australian Institute for Bioengineering and Nanotechnology is set to provide researchers with cancer vaccines tailored to individual patients.

A new parcel of federal funding will help AIBN researchers produce clinical-grade mRNA products that are safer and better quality, and will potentially cost less.

By feeding waste gases like carbon dioxide, carbon monoxide, and methane to certain bacteria, Antonia Ebert is producing bioplastics that break down naturally in the environment.

A blue-sky vision for a new, durable green polymer has won AIBN researchers global recognition at the 2024 Serendipity Collective competition in Estonia.

AIBN researchers are at the heart of a new era for medical research, one that will boost local biomanufacturing and help seriously unwell patients.

Heart disease is a major killer in Australia – but researchers are a beat closer to remuscularising your dodgy ticker with a lab grown solution.

AIBN researcher Dr Nick Fletcher has won an Advance Queensland Industry Research Fellowship to explore localised cell death and the immune response to cancer.